US Bancorp
AYTU icon

US Bancorp’s AYTU BioPharma AYTU Stock Holding History

US Bancorp’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-57
Closed -$97 – 4198
2024
Q4 		$97 Buy
57
+54
+1,800% +$99 ﹤0.01% 4109
2024
Q3 		$7 Sell
3
-6
-67% -$16 ﹤0.01% 4069
2024
Q2 		$26 Buy
+9
New +$27 ﹤0.01% 3949
2023
Q1 		– Hold
0
– – – 4089
2022
Q4 		– Hold
0
– – – 4143
2022
Q3 		– Hold
0
– – – 4061
2022
Q2 		– Hold
0
– – – 4075
2022
Q1 		– Hold
0
– – – 4061
2021
Q4 		– Hold
0
– – – 4094
2021
Q3 		– Hold
0
– – – 4074
2021
Q2 		– Hold
0
– – – 3992
2021
Q1 		– Hold
0
– – – 3875
2020
Q4 		– Hold
0
– – – 3761
2020
Q3 		– Hold
0
– – – 3705

Other funds holding AYTU

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

US Bancorp's AYTU Position: Q1 2025 in Review

US Bancorp sold out of AYTU BioPharma (AYTU) in Q1 2025, closing a stake of 57 shares — an estimated $97 sold.

US Bancorp first reported a position in AYTU in Q2 2024 and held it in 3 quarters. The position peaked at $97 in Q4 2024. 31 funds tracked by Wall St. Rank hold AYTU as of Q1 2025.

  • US Bancorp reported no remaining AYTU BioPharma position as of Q1 2025 after selling out during the quarter.
  • US Bancorp sold 57 AYTU BioPharma shares in Q1 2025, an estimated $97.
  • US Bancorp first reported a position in AYTU BioPharma in Q2 2024 and held it in 3 quarters.
  • US Bancorp's AYTU BioPharma position peaked at $97 in Q4 2024.
  • 31 funds tracked by Wall St. Rank held AYTU BioPharma as of Q1 2025.

Based on US Bancorp's 13F filing for Q1 2025, filed 8 May 2025.